A category with real content
Research use only marks a substance intended for laboratory investigation rather than for administration to people or animals. It is a recognised category in how chemicals are supplied and regulated, not a phrase invented by suppliers.
The practical consequence is that the material has not been through the assessment a medicine goes through. No regulator has evaluated it for safety in humans, no authority has approved an indication, and there is no licensed dose because there is no licence.
That absence is the point of the classification. It marks the boundary between substances a regulator has examined and substances that have not been examined at all.
The category has a legal home as well as a practical meaning. The REACH regulation, the EU framework for chemicals, defines scientific research and development as a distinct activity and treats substances handled under it differently from substances placed on the market for other purposes, and ECHA, which runs the registration system, publishes the guidance on that distinction. None of that makes a research chemical a medicine by another name. It shows that EU law already has a place for substances handled in laboratories rather than given to patients, and the four words point to that place.
Four consequences that actually follow
This is what the classification changes in practice.
Why we do not write around this
A good deal of this industry treats the label as a formality: the words appear in the footer, and the product copy is written as though they were not there. That approach works until somebody is harmed or a regulator reads the page.
We would rather the classification appear where it is relevant and mean what it says. It costs us some conversions from people who wanted a different answer, and it means the answer we give is the same one we would give a regulator.
It also means that when we do say something definite, about purity, about a batch, about what a study found, you have reason to think we are not simply saying what suits us.
The classification also has consequences outside the shop, and those are the easiest to miss. It says nothing about sport: the WADA page sets out which parts of this catalogue are prohibited for anyone competing under anti-doping rules, and the label on the vial is no defence there. And it says nothing to a customs officer or a security screener, which is what the travelling page is for.
- Recommend a doseThere is no approved dose. Anyone quoting one is inventing it, however confidently.
- Describe effects in peopleThe evidence base for most of this material is animal and laboratory work. We say so on the pages.
- Imply medical supervisionWe are a supplier of research material. We are not a clinic and we do not employ prescribers.
- Sell to anyone under 18A firm line, applied regardless of what the order says about intended use.
Related pages
The legal and practical context around this classification.
About the classification
The questions this label generates most.